Physician profile
Timothy Alexander Abston
NPI 1255658589
$5,485.50
in general payments reported to CMS, 2019-2025
46 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $180 · 2021: $913 · 2022: $1,001 · 2023: $898 · 2024: $1,024 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,999.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $725.62 | 2021-2025 | Dalvance, Strattice Reconstructive Tissue Matrix Bps |
| Takeda Pharmaceuticals U.S.A., INC. | $646.99 | 2020-2025 | Gattex |
| Davol INC. | $619.53 | 2019-2025 | Phasix Mesh |
| Kerecis Limited | $538.71 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Intuitive Surgical, INC. | $343.73 | 2019-2025 | Da Vinci Surgical System |
| Allergan, INC. | $329.70 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $258.86 | 2020-2025 | Myrisk |
| Medtronic, INC. | $250.81 | 2022-2025 | Symbotex, Signia |
| Ethicon US, LLC | $169.70 | 2021-2025 | Linx Reflux Management System, Harmonic |
| Tela Bio, INC. | $136.48 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $113.89 | 2024-2025 | Coolseal Generator, Trunode, Localizer |
| Csl Behring | $111.38 | 2019-2021 | |
| Tetraphase Pharmaceuticals, INC. | $81.50 | 2019-2020 | |
| Organogenesis INC. | $76.77 | 2023-2025 | Affinity, Puraply |
| Polynovo North America LLC | $73.84 | 2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molli Surgical (US) INC | $62.38 | 2024 | |
| Hydrofera LLC | $53.28 | 2025 | Hydrofera Blue |
| Access Pro Medical, LLC | $52.43 | 2022 | |
| Integra Lifesciences Corporation | $52.33 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Vertex Pharmaceuticals Incorporated | $51.99 | 2024-2025 | |
| Innovation Technologies INC | $50.65 | 2024-2025 | Irrisept |
| Smith+Nephew, INC. | $49.64 | 2022-2025 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $48.95 | 2022-2024 | Bridion |
| Conmed Corporation | $48.28 | 2023-2024 | Airseal, Conmed Trocars |
| Convatec INC. | $47.20 | 2023-2025 | |
| Shire North American Group INC | $39.51 | 2019 | |
| Baxter Healthcare | $38.90 | 2021-2022 | |
| Solventum Corporation | $38.52 | 2024-2025 | Prevena |
| Boston Scientific Corporation | $37.55 | 2021 | |
| Trevena, INC. | $35.71 | 2021-2022 | |
| Carl Zeiss Meditec, INC. | $32.22 | 2019 | |
| Sanara Medtech INC. | $30.63 | 2022-2023 | Celleraterx |
| Coopersurgical, INC. | $30.18 | 2025 | Onetrac Lx |
| Heron Therapeutics, INC. | $28.30 | 2021-2022 | |
| Lsi Solutions INC | $27.84 | 2019 | |
| Innocoll Pharmaceuticals Limited | $20.44 | 2021 | |
| Enterra Medical, INC. | $18.78 | 2022 | |
| Misonix INC | $16.04 | 2020 | |
| Hologic INC | $14.92 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.46 | 2022 | |
| Zimmer Biomet Holdings, INC. | $14.02 | 2024 | Ribfix Blu Advantage |
| Endogastric Solutions, INC | $13.98 | 2022 | |
| Lucid Diagnostics INC. | $13.22 | 2024 | |
| Kci USA, INC. | $12.84 | 2022 | |
| Medela LLC | $8.50 | 2020 | |
| Bolder Surgical LLC | $4.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Abston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.